Shares of Epigral Limited, a specialty chemical company, advanced over four percent to Rs 1,380 on April 3 after successful commissioning of an additional 45,000 TPA (tonnes per annum) capacity of CPVC (Chlorinated Polyvinyl Chloride) resin plant at its Dahej facility in Gujarat. Post the addition, the total capacity now stands at 75,000 TPA, positioning it as the largest CPVC resin facility in the world at a single location.
Alongside expanding its CPVC resin capacity, Epigral is diversifying into CPVC compound production, with a projected capacity of 35,000 TPA (tons per annum). The project is currently underway and is anticipated to be operational by the first quarter of the financial year 2025.
Follow our live blog for all the market action
CPVC resin and compound play vital roles in producing CPVC pipes and fittings, known for their exceptional heat and chemical resistance making it ideal for various domestic and industrial uses. The company said that India's demand for CPVC stands at around 250,000 tonnes per annum (TPA), and continues to grow steadily, with an anticipated annual growth rate ranging between 10 percent and 13 percent.
"With the commissioning of the CPVC resin plant, we are advancing towards our goal of becoming a multi-product company, geared up to enhance revenue contribution from the derivatives and specialty chemical segment," the management highlighted.
At 2:15 pm, the stock was trading at Rs 1,356, up 2.5 percent from the previous close on the NSE. In the last three months, the counter has gained 28 percent.
Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
